1887
Volume 2013, Issue 2
  • ISSN: 2305-7823
  • E-ISSN:

There is no abstract available for this article.

Loading

Article metrics loading...

/content/journals/10.5339/gcsp.2013.17
2013-08-01
2019-08-17
Loading full text...

Full text loading...

/deliver/fulltext/gcsp/2013/2/gcsp.2013.17.html?itemId=/content/journals/10.5339/gcsp.2013.17&mimeType=html&fmt=ahah

References

  1. [1]. Breet   NJ., , van Werkum   JW., , Bouman   HJ., , Kelder   JC., , Ruven   HJ., , Bal   ET., , Deneer   VH., , Harmsze   AM., , van der Heyden   JA., , Rensing   BJ., , Suttorp   MJ., , Hackeng   CM., , ten Berg   JM. . Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. . JAMA . 2011; ;305: 21 : 2172– 2174
    [Google Scholar]
  2. [2]. Buonamici   P., , Marcucci   R., , Migliorini   A., , Gensini   GF., , Santini   A., , Paniccia   R., , Moschi   G., , Gori   AM., , Abbate   R., , Antoniucci   D. . Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. . J Am Coll Cardiol . 2007; ;49: 24 : 2312– 2317
    [Google Scholar]
  3. [3]. Brar   SS., , ten Berg   J., , Marcucci   R., , Price   MJ., , Valgimigli   M., , Kim   HS., , Patti   G., , Breet   NJ., , DiSciascio   G., , Cuisset   T., , Dangas   G. . Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention: a collaborative meta-analysis of individual participant data. . J Am Coll Cardiol . 2011; ;58: 19 : 1945– 1954
    [Google Scholar]
  4. [4]. Cuisset   T., , Frere   C., , Quilici   J., , Morange   PE., , Mouret   JP., , Bali   L., , Moro   PJ., , Lambert   M., , Alessi   MC., , Bonnet   JL. . Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study. . JACC Cardiovasc Interv . 2008; ;1: 6 : 649– 653
    [Google Scholar]
  5. [5]. Valgimigli   M., , Campo   G., , de Cesare   N., , Meliga   E., , Vranckx   P., , Furgieri   A., , Angiolillo   DJ., , Sabatè   M., , Hamon   M., , Repetto   A., , Colangelo   S., , Brugaletta   S., , Parrinello   G., , Percoco   G., , Ferrari   R., , Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3 T/2R) Investigators. . Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study. . Circulation . 2009; ;119: 25 : 3215– 3222
    [Google Scholar]
  6. [6]. Trenk   D., , Stone   GW., , Gawaz   M., , Kastrati   A., , Angiolillo   DJ., , Müller   U., , Richardt   G., , Jakubowski   JA., , Neumann   FJ. . A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study. . J Am Coll Cardiol . 2012; ;59: 24 : 2159– 2164
    [Google Scholar]
  7. [7]. Price   MJ., , Berger   PB., , Teirstein   PS., , Tanguay   JF., , Angiolillo   DJ., , Spriggs   D., , Puri   S., , Robbins   M., , Garratt   KN., , Bertrand   OF., , Stillabower   ME., , Aragon   JR., , Kandzari   DE., , Stinis   CT., , Lee   MS., , Manoukian   SV., , Cannon   CP., , Schork   NJ., , Topol   EJ. . GRAVITAS Investigators Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. . JAMA . 2011; ;305: 11 : 1057– 1097
    [Google Scholar]
  8. [8]. Aradi   D., , Komócsi   A., , Price   MJ., , Cuisset   T., , Ari   H., , Hazarbasanov   D., , Trenk   D., , Sibbing   D., , Valgimigli   M., , Bonello   L., , On behalf of the Tailored Antiplatelet Treatment Study Collaboration. . Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: systematic review and meta-analysis. . Int J Cardiol . 2012 Jun 15; ; , [Epub ahead of print]
    [Google Scholar]
  9. [9]. Collet   JP., , Cayla   G., , Cuisset   T., , Elhadad   S., , Rangé   G., , Vicaut   E., , Montalescot   G. . Randomized comparison of platelet function monitoring to adjust antiplatelet therapy versus standard of care: rationale and design of the assessment with a double randomization of (1) a fixed dose versus a monitoring-guided dose of aspirin and clopidogrel after DES implantation, and (2) treatment interruption versus continuation, 1 year after stenting (ARCTIC) study. . Am Heart J . 2011; ;161: 1 : 5e5– 12e5
    [Google Scholar]
  10. [10]. Montalescot   G., , White   HD., , Gallo   R., , Cohen   M., , Steg   PG., , Aylward   PE., , Bode   C., , Chiariello   M., , King   SB 3rd., , Harrington   RA., , Desmet   WJ., , Macaya   C., , Steinhubl   SR., , for the STEEPLE Investigators. . Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. . N Engl J Med.   2006; ;   355 : 1006– 1017
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/gcsp.2013.17
Loading
  • Article Type: Research Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error